Oxidation of fatty acids, energy yield, carnitine system.
Introduction[edit | edit source]
Fatty acids are a major source of energy, especially during fasting, prolonged exercise, or starvation. The oxidation of fatty acids occurs primarily in the mitochondria of liver and muscle cells. Long-chain fatty acids, the most abundant dietary type, require carnitine-dependent transport into the mitochondrial matrix before undergoing β-oxidation. The process releases large amounts of ATP, particularly from long-chain saturated fatty acids.
Activation of fatty acids[edit | edit source]
Before oxidation, free fatty acids must be activated in the cytosol to form acyl-CoA derivatives. This reaction is catalyzed by acyl-CoA synthetase (thiokinase):
Fatty acid + CoA + ATP → Acyl-CoA + AMP + PPi
This step consumes two high-energy phosphate bonds (equivalent to 2 ATP).
Source: Nelson DL, Cox MM. Lehninger Principles of Biochemistry. 8th ed. 2021.
Carnitine transport system[edit | edit source]
Long-chain acyl-CoA cannot directly cross the inner mitochondrial membrane. Instead, it uses the carnitine shuttle, consisting of three major components:
1. Carnitine palmitoyltransferase I (CPT I)[edit | edit source]
Located on the outer mitochondrial membrane, CPT I transfers the acyl group from CoA to carnitine, forming acylcarnitine:
Acyl-CoA + Carnitine → Acylcarnitine + CoA
CPT I is inhibited by malonyl-CoA, a key intermediate in fatty acid synthesis, preventing simultaneous synthesis and degradation of fatty acids.
2. Carnitine-acylcarnitine translocase[edit | edit source]
This inner membrane transporter exchanges acylcarnitine into the mitochondrial matrix while exporting free carnitine.
3. Carnitine palmitoyltransferase II (CPT II)[edit | edit source]
Located on the inner surface of the inner mitochondrial membrane, CPT II transfers the acyl group back from carnitine to CoA, regenerating mitochondrial acyl-CoA:
Acylcarnitine + CoA →Acyl-CoA + Carnitine
Source: Murray RK et al. Harper’s Illustrated Biochemistry. 31st ed. 2018.
β-oxidation of fatty acids[edit | edit source]
Occurs in the mitochondrial matrix and involves repeated removal of two-carbon units as acetyl-CoA from the carboxyl end of acyl-CoA. Each cycle of β-oxidation consists of four main reactions:
1. Oxidation[edit | edit source]
Acyl-CoA dehydrogenase introduces a trans double bond between C2 and C3, generating FADH₂:
Acyl-CoA → trans-Δ²-enoyl-CoA + FADH2
2. Hydration[edit | edit source]
Enoyl-CoA hydratase adds water across the double bond:
trans-Δ²-enoyl-CoA → L-3-hydroxyacyl-CoA
3. Oxidation[edit | edit source]
L-3-hydroxyacyl-CoA dehydrogenase oxidizes the hydroxyl group to a keto group, forming NADH:
L-3-hydroxyacyl-CoA → 3-ketoacyl-CoA + NADH
4. Thiolysis[edit | edit source]
β-ketothiolase cleaves 3-ketoacyl-CoA to produce acetyl-CoA and a shortened acyl-CoA (by two carbons):
3-ketoacyl-CoA + CoA → Acetyl-CoA + Acyl-CoA (n-2)
Source: Marks DB et al. Marks’ Basic Medical Biochemistry: A Clinical Approach. 5th ed. 2017.
Energy yield[edit | edit source]
Complete oxidation of palmitic acid (C16:0) yields:
- 8 acetyl-CoA → enters TCA cycle
- 7 FADH₂ → 1.5 ATP each = 10.5 ATP
- 7 NADH → 2.5 ATP each = 17.5 ATP
- Total from β-oxidation: 28 ATP
- Acetyl-CoA via TCA cycle and oxidative phosphorylation → ~80 ATP
- Minus 2 ATP for activation → Net yield: ~106 ATP
Source: Devlin TM. Textbook of Biochemistry with Clinical Correlations. 7th ed. 2010.
Regulation[edit | edit source]
Allosteric regulation[edit | edit source]
- Malonyl-CoA inhibits CPT I → prevents β-oxidation during fatty acid synthesis
- High NADH/FADH₂ inhibits β-oxidation enzymes via product feedback
- High AMP → activates AMPK → inhibits acetyl-CoA carboxylase → ↓ malonyl-CoA → ↑ β-oxidation
Hormonal regulation[edit | edit source]
- Insulin inhibits lipolysis and β-oxidation
- Glucagon and epinephrine stimulate lipolysis in adipose tissue → increase FFA availability → promote β-oxidation
Clinical significance[edit | edit source]
Carnitine deficiency[edit | edit source]
Can be primary (genetic) or secondary (e.g., due to malnutrition, liver disease, or hemodialysis). Leads to impaired transport of long-chain fatty acids into mitochondria.
Symptoms:
- Hypoketotic hypoglycemia
- Muscle weakness
- Cardiomyopathy
Treatment: Oral carnitine supplementation
Medium-chain acyl-CoA dehydrogenase deficiency (MCAD)[edit | edit source]
Autosomal recessive disorder affecting the second step of β-oxidation. Most common inherited fatty acid oxidation disorder.
Symptoms:
- Hypoketotic hypoglycemia during fasting
- Vomiting
- Seizures
- Sudden infant death
Diagnosis: Acylcarnitine profile, urinary dicarboxylic acids
Treatment: Avoid fasting, high-carb diet
Refsum disease[edit | edit source]
Defect in α-oxidation of phytanic acid (branched-chain fatty acid). Not a β-oxidation defect per se, but related.
Symptoms:
- Retinitis pigmentosa
- Cerebellar ataxia
- Peripheral neuropathy
Treatment: Avoid phytanic acid in diet (found in dairy and meat of ruminants)
Peroxisomal β-oxidation[edit | edit source]
Very long-chain fatty acids (≥ C22) are first shortened in peroxisomes before being transferred to mitochondria.
- Similar steps to mitochondrial β-oxidation
- Generates H₂O₂ (requires catalase for detoxification)
- Does not produce ATP directly
Source: Zempleni J, Suttie JW, Gregory JF III, Stover PJ. Present Knowledge in Nutrition. 10th ed. 2012.
Summary[edit | edit source]
Fatty acid β-oxidation is a crucial mitochondrial process for energy production, especially in fasting states. Long-chain fatty acids must be transported into mitochondria by the carnitine shuttle, then degraded in a cyclic four-step β-oxidation pathway. This process is tightly regulated and interconnected with carbohydrate metabolism. Inherited defects in the transport or oxidation systems can result in severe metabolic disorders, often presenting with hypoglycemia and muscle-related symptoms.
